Changes in the Board of Executive Directors of BASF
Business & Financial News
|
December 17, 2020
Global
Melanie Maas-Brunner appointed to the Board and succeeds Wayne T. Smith
Redistribution of responsibilities effective February 1, 2021 and June 1, 2021
Ludwigshafen, Germany – December 17, 2020 – The Supervisory Board of BASF SE today appointed Dr. Melanie Maas-Brunner (52) as a member of the Board of Executive Directors effective February 1, 2021. Maas-Brunner has been with BASF since 1997 and has headed BASF’s Nutrition & Health division since 2017. In her new role as of February 1, 2021, she will also take over the position as Chief Technology Officer from Dr. Martin Brudermüller, Chairman of the Board of Executive Directors of BASF. She will assume responsibility for the three research divisions Advanced Materials & Systems Research, Bioscience Research, Process Research & Chemical Engineering as well as BASF New Business at that time.